...
首页> 外文期刊>Applied radiation and isotopes: including data, instrumentation and methods for use in agriculture, industry and medicine >'2+1' Tricarbonyltechnetium(I) and -rhenium(I) mixed-ligand complexes with N-methylpyridine-2-carboxyamide and isocyanide or imidazole ligands-potential precursors of radiopharmaceuticals.
【24h】

'2+1' Tricarbonyltechnetium(I) and -rhenium(I) mixed-ligand complexes with N-methylpyridine-2-carboxyamide and isocyanide or imidazole ligands-potential precursors of radiopharmaceuticals.

机译:'2 + 1'三羰基tech(I)和-(I)与N-甲基吡啶-2-羧酰胺和异氰酸酯或咪唑配体的潜在配体复合物-放射性药物的潜在前体。

获取原文
获取原文并翻译 | 示例
           

摘要

Complexes of tricarbonyltechnetium(I)-99m and rhenium(I)-188, of '2+1' type: with N-methylpyridine-2-carboxyamide as a neutral bidentate ligand and either tert-butyl 3-isocyanopropionate or imidazole as a monodentate ligand, have been obtained on n.c.a. level. The complexes exhibit moderate lipophilicity and rather high stability in neutral aqueous solutions. The latter has been evidenced from the tests on histidine/cysteine challenge and on protein binding in rat serum. The rhenium complexes studied are much more stable than their technetium analogues. The isocyanopropionate complex may be considered promising model for radiopharmaceutical precursors.
机译:'2 + 1'型三羰基tech(I)-99m和rh(I)-188的配合物:N-甲基吡啶-2-羧酰胺为中性双齿配体,3-异氰基丙酸叔丁酯或咪唑为单齿配体,已在nca上获得水平。该络合物在中性水溶液中显示适度的亲脂性和相当高的稳定性。后者已通过对组氨酸/半胱氨酸攻击和大鼠血清中蛋白质结合的测试得到了证明。所研究的complex配合物比tech类似物稳定得多。异氰酸丙酸酯复合物可以被认为是放射性药物前体的有前途的模型。

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号